| Bioactivity | Histone H3K9me3 (1-15) (H3(1-15)K9me3) is a histone posttranslational modification (PTM) that has emerged as hallmark of pericentromeric heterochromatin. Trimethylation of histone H3 at lysine 9 is associated with gene repression, prevents transcription factor binding[1][2]. |
| Name | Histone H3K9me3 (1-15) |
| CAS | 951011-30-6 |
| Sequence | Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-{Lys(Me3)}-Ser-Thr-Gly-Gly-Lys-Ala |
| Shortening | ARTKQTAR-{Lys(Me3)}-STGGKA |
| Formula | C66H124N25O21+ |
| Molar Mass | 1603.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Woon EC, et al. Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylases. Angew Chem Int Ed Engl. 2012 Feb 13;51(7):1631-4. [2]. Mosch K, et al. HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats. PLoS One. 2011 Jan 18;6(1):e15894. |
Histone H3K9me3 (1-15)
CAS: 951011-30-6 F: C66H124N25O21+ W: 1603.85
Histone H3K9me3 (1-15) (H3(1-15)K9me3) is a histone posttranslational modification (PTM) that has emerged as hallmark of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.